Table 2.
Association analysis between hematologic biomarkers and progress to death in patients admitted for COVID-19 in hospitals in the central region of Brazil from March to August 2020.
| Hematologic biomarker | Total of patients Mean (SD) | Final outcome |
p∗ | |
|---|---|---|---|---|
| Death Mean (SD) | High Mean (SD) | |||
| Total leukocytes (/mm3) | 9.193 (5.783) | 13.592 (8.862) | 8.372 (4.556) | <0.001 |
| Neutrophils (/mm3) | 7.318 (5.512) | 11.770 (8.277) | 6.476 (4.290) | <0.001 |
| Monocytes (/mm3) | 582 (432) | 744 (621) | 549 (383) | 0.066 |
| Lymphocytes (/mm3) | 1.261 (728) | 1.011 (614) | 1.306 (747) | 0.013 |
| Neutrophil/lymphocyte ratio | 7.81 (8.09) | 15.0 (11.9) | 6.44 (6.25) | <0.001 |
| Monocyte/lymphocyte ratio | 0.56 (0.55) | 0.88 (0.68) | 0.50 (0.50) | <0.001 |
SD: standard deviation.
∗Mann-Whitney non-parametric test.